Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

2015277 citationsJournal Articlehybrid Open Access

Authors

Cancer Research UK and AstraZeneca Pharmaceuticals.

Good health and well-being

Published in: The Lancet Oncology

Volume 16, Issue 8, pp. 967-978

Field-Weighted Citation Impact: 21.54